Clinical trial

Use of a Nutritional Supplement to Treat Diabetic Symptoms in HIV-Infected…

NCT00109746 · National Center for Complementary and Integrative Health (NCCIH), NIH · Completed

Key facts

NCT number NCT00109746
Title Use of a Nutritional Supplement to Treat Diabetic Symptoms in HIV-Infected Adults
Official title A Novel Therapy for Glucose Intolerance in HIV Disease
Acronym NT
Lead sponsor National Center for Complementary and Integrative Health (NCCIH), NIH
Collaborators Office of Dietary Supplements (ODS) NIH
Status Completed
Phase Phase 1/Phase 2
Study type Interventional
Conditions Insulin Resistance, HIV Infections
Intervention type Dietary Supplement
Interventions chromium picolinate
Enrollment 39
Start date Nov 1, 2005
Primary completion May 1, 2009
Completion Jun 1, 2010
First posted May 3, 2005
Last update posted Mar 23, 2016
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies